What Prestin, the Inner Ear's Molecular Motor, Does and What's Unknown

Prestin, a protein inside the inner ear, is drawing attention from two research groups asking different questions. At UConn Health, researchers are testing whether blood levels of prestin can signal tinnitus. At Yale School of Medicine, a new grant will fund work on how prestin actually works, with the aim of treating gradual hearing loss.

The two projects are separate, and neither has produced a treatment. Together they show how much of prestin's behavior is still unexplained.

What prestin does inside the cochlea

The cochlea is the snail-shaped organ of the inner ear. According to UConn Today, it contains outer hair cells, specialized cells that amplify sound vibrations and fine-tune hearing sensitivity. Prestin sits in the wall of these cells, which grow longer or shorter depending on how intense a sound is.

Yale describes prestin as a motor protein that drives cochlear amplification, which it likens to hearing volume. New Atlas also calls it a kind of molecular motor in the cell membrane. Yale says the motor becomes less efficient when hearing declines gradually with age or other factors.

Yale's question: what keeps the motor fast

Yale School of Medicine announced that Joseph Santos-Sacchi, a professor of surgery who directs the Yale Ear Lab, received a five-year, $3.5 million grant from the National Institute on Deafness and Other Communication Disorders. The money also pays for two researcher positions.

The project will test what controls prestin's speed and how it responds to stress. One example is the stiffness of the outer hair cell membrane. According to Yale, stiffness can alter a measure called nonlinear capacitance, an electrical property that makes amplification possible. The team wants to produce a blueprint that could guide treatments such as gene therapies. Santos-Sacchi said he hopes the work will refine hearing loss treatments and "possibly even prevent it."

UConn's question: can blood reveal tinnitus

UConn Today reported that Kourosh Parham's team found elevated prestin in people with chronic tinnitus in two studies, published in March and July. The earlier study compared 49 people with tinnitus with 40 controls. The later one used 41 and 41, according to both UConn Today and New Atlas. Parham's idea is that some prestin leaks into the bloodstream and reflects what is happening in the outer hair cells.

What this still does not explain

Several gaps remain, and they differ for each project.

• Where the blood prestin comes from. New Atlas reported that prestin is strongly tied to the inner ear but has also been found in other tissue, including the heart. The researchers say their findings do not prove tinnitus starts in the cochlea.
• Ear or brain. Tinnitus can involve both the ear and the central auditory system, and New Atlas said the study could not tell these apart.
• Severity. Parham told UConn Today that measuring prestin gives a clinical indication of how bad tinnitus is. New Atlas reported that prestin levels did not rise with symptom severity in the study, and that most participants had mild tinnitus. The accounts differ, and the question is not settled.
• Reliability. New Atlas said the method was not accurate enough to be dependable for diagnosis. UConn Today said the results need to be replicated in a larger group.
• From mechanics to therapy. Yale describes gene therapies as a goal of the grant, not a result. The work starts with mapping how prestin controls speed, especially at ultra-high frequencies.

Even the basic scale of tinnitus is reported differently. UConn Today put it at approximately 11% of Americans and 15% of people worldwide, while New Atlas cited 14%.

Why it matters for people with hearing problems

For now, nothing changes for patients. No prestin blood test is available for diagnosing tinnitus in the sources, and no prestin-based drug or gene therapy exists. UConn Today said doctors have had to rely on patients' own accounts of symptoms, such as how well they sleep or how stressed they feel. A measurable biological signal could add a second source of information, even an imperfect one, as New Atlas put it.

The Yale work targets a different problem: gradual hearing loss tied to aging and other factors. Understanding why prestin slows down could eventually point to ways to protect it.

What comes next

Yale's grant runs five years, so results are not expected soon. On the UConn side, New Atlas said larger studies are needed to show whether the test can reliably identify tinnitus, separate different forms of it, or help doctors choose treatments. Parham has said he hopes the findings will lead to a drug for the condition.

Earlier on Around Prague: Blood Test Study Links Ear Protein Prestin to Tinnitus, With 50% Higher Levels

Read next
Blood Test Study Links Ear Protein Prestin to Tinnitus, With 50% Higher Levels
Perseverance Rover Finds Ruby-Like Mineral Glowing Red on Mars
Curiosity Rover Drills Rock Packed With Possible Crystals on Mars

Around Prague, based on reporting by Yale School of Medicine, New Atlas, UConn Today